Ceftazidime Resistant Bacteria in Clinical Samples: Do We Need New Antibiotics? | PSM Publishers | Nonprofit Scientific Publishing
EDITORIAL: Antibiotic resistant strains and species referred to as ''super bugs'' contribute to emergence of disease. Antibiotic resistant bacterial infections have become a threat, in particular in developing countries. Incidence and mortality from infectious diseases have increased during the past decade. Antibiotic resistance causes biological cost by reducing fitness of resistant strains, which can minimize the spread of resistant bacteria. Additional mutations also aid in the survival of resistant bacteria (Topp et al., 2013). Microbes that are resistant to multiple antimicrobials are called multidrug resistant (MDR) (Iqbal et al., 2015a). Antibiotics are among the most commonly prescribed drugs in hospitals and in developed countries about 30% of the hospitalized patients are treated with these drugs (Shankar et al., 2003). In this issue, Saleem et al. report the Ceftazidime resistance in clinical isolates of bacteria. The proportions of resistant isolates to Ceftazidime ranged E